| Factors affecting motivation and retention of primary health care workers in three disparate regions in Kenya D Ojakaa, S Olango, J Jarvis Human resources for health 12, 1-13, 2014 | 231 | 2014 |
| Overcoming obstacles to enable access to medicines for noncommunicable diseases in poor countries SP Kishore, K Kolappa, JD Jarvis, PH Park, R Belt, T Balasubramaniam, ... Health Affairs 34 (9), 1569-1577, 2015 | 27 | 2015 |
| Engaging young people in the prevention of noncommunicable diseases R Baker, E Taylor, S Essafi, JD Jarvis, C Odok Bulletin of the World Health Organization 94 (7), 484, 2016 | 25 | 2016 |
| Acceptance of a malaria vaccine by caregivers of sick children in Kenya DI Ojakaa, JD Jarvis, MI Matilu, S Thiam Malaria Journal 13, 1-12, 2014 | 24 | 2014 |
| Selection of WHO-recommended essential medicines for non-communicable diseases on National Essential Medicines Lists JD Jarvis, H Woods, A Bali, E Oronsaye, N Persaud PloS one 14 (8), e0220781, 2019 | 20 | 2019 |
| Community health workers: An underappreciated asset to tackle NCD JD Jarvis, I Kataria, M Murgor, L Mbau Elsevier Ltd., 2016 | 15 | 2016 |
| Tyrosine kinase chromosomal translocations mediate distinct and overlapping gene regulation events H Kim, LC Gillis, JD Jarvis, S Yang, K Huang, S Der, DL Barber BMC cancer 11, 1-16, 2011 | 14 | 2011 |
| A comparison of national essential medicines lists in the Americas L Steiner, D Maraj, H Woods, J Jarvis, H Yaphe, I Adekoya, A Bali, ... Revista Panamericana de Salud Pública 44, 2020 | 10 | 2020 |
| NOACs added to WHO’s essential medicines list: recommendations for future policy actions M Di Cesare, JD Jarvis, O Scarlatescu, X Leng, EJ Zaidel, E Burrone, ... Global heart 15 (1), 2020 | 9 | 2020 |
| Acceptability and feasibility of a national essential medicines list in Canada: a qualitative study of perceptions of decision-makers and policy stakeholders JD Jarvis, A Murphy, P Perel, N Persaud Cmaj 191 (40), E1093-E1099, 2019 | 9 | 2019 |
| NCDs and the WHO essential medicines lists: children need universal health coverage too NJ Gray, JP Chanoine, MY Farmer, JD Jarvis, K Armstrong, RD Barr, ... The Lancet Child & Adolescent Health 3 (11), 756-757, 2019 | 3 | 2019 |
| Equitable access to global health internships: a documentary short T Kedia, A Barnett-Vanes, J Jarvis, K Ragins, C Long, O Owaseye, ... The Lancet Global Health 6 (2), e145, 2018 | 3 | 2018 |
| The Road to Addressing Noncommunicable Diseases and Cancer in Global Health Policy H Catoe, J Jarvis, S Gupta, O Ginsburg, G de Lima Lopes Jr American Society of Clinical Oncology educational book. American Society of …, 2017 | 3 | 2017 |
| A Global Social Network to Catalyze Solutions for Chronic NCD JD Jarvis, E Obscherning, K Siegel, SP Kishore Global Heart 11 (4), 463, 2016 | 3 | 2016 |
| Young people have a new vision for essential medicines SR Mishra, SWS Li, KH Onarheim, F Lander, MJ Barber, A Sharma, ... The Lancet Diabetes & Endocrinology 4 (9), 733-734, 2016 | 2 | 2016 |
| Making essential medicines accessible: Policy analysis of the revision and implementation of the national essential medicines list in Kenya JD Jarvis London School of Hygiene & Tropical Medicine, 2022 | | 2022 |
| Universal health coverage for the poorest billion: justice and equity considerations JD Jarvis, B Townsend The Lancet 397 (10273), 473-474, 2021 | | 2021 |
| Turning the tide on NCDs by engaging the next generation P Bhatnagar, J Fisher, J Renzella, I Kataria, JD Jarvis The Lancet 390 (10105), 1829-1830, 2017 | | 2017 |
| Youth demand action on the shared global challenge of access to medicines TLYCEM Policies The Lancet 389, 345-347, 2016 | | 2016 |
| Submission to the United Nations Secretary General's High-Level Panel on Access to Medicines J Jarvis, TLYCEM Policies http://www.unsgaccessmeds.org/inbox/2016/2/29/0c87t0dtsq8u5k6crci4ttc8d2sw7q, 2016 | | 2016 |
